Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to -$879000.0.

  • Dolby Laboratories' Change in Inventory rose 3440.3% to -$879000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.6 million, marking a year-over-year increase of 532.38%. This contributed to the annual value of -$8.0 million for FY2025, which is 40214.77% down from last year.
  • Latest data reveals that Dolby Laboratories reported Change in Inventory of -$879000.0 as of Q4 2025, which was up 3440.3% from -$4.0 million recorded in Q3 2025.
  • Dolby Laboratories' Change in Inventory's 5-year high stood at $10.8 million during Q3 2023, with a 5-year trough of -$6.0 million in Q1 2021.
  • In the last 5 years, Dolby Laboratories' Change in Inventory had a median value of -$1.1 million in 2024 and averaged $300550.0.
  • Per our database at Business Quant, Dolby Laboratories' Change in Inventory plummeted by 21054.74% in 2021 and then skyrocketed by 238834.75% in 2023.
  • Over the past 5 years, Dolby Laboratories' Change in Inventory (Quarter) stood at $1.8 million in 2021, then plummeted by 72.46% to $501000.0 in 2022, then surged by 1755.69% to $9.3 million in 2023, then plummeted by 114.41% to -$1.3 million in 2024, then soared by 34.4% to -$879000.0 in 2025.
  • Its Change in Inventory stands at -$879000.0 for Q4 2025, versus -$4.0 million for Q3 2025 and -$5.2 million for Q2 2025.